O spoločnosti StandardX
StandardX vyvíja kompaktnú platformu s výkonným časticovým urýchľovačom, ktorá má vyrábať rôzne izotopy v štandardizovanej zostave. Spoločnosť vznikla v roku 2025 a spočiatku sa zameriava na dodávky izotopov na diagnostiku a liečbu rakoviny, výskum a budúce fúzne systémy.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.